1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Real-time Estimate Cboe BZX  -  11:00 2022-06-28 am EDT
145.71 USD   +0.24%
06/27INSIDER SELL : Moderna
MT
06/27US grapples with whether to modify COVID vaccine for fall
AQ
06/27INSIDER SELL : Moderna
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Transcript : Moderna, Inc. Presents at UBS Global Healthcare Conference, May-24-2022 09:15 AM

05/24/2022 | 09:15am EDT
Hi. Good morning, everyone. I'm Ellie Merle. I'm one of the biotech analysts here at UBS. Thank you so much for joining us at the UBS Healthcare Conference in person. Very happy to have Moderna...


© S&P Capital IQ 2022
All news about MODERNA, INC.
06/27INSIDER SELL : Moderna
MT
06/27US grapples with whether to modify COVID vaccine for fall
AQ
06/27INSIDER SELL : Moderna
MT
06/26Moderna Seeks Swissmedic's Approval Extension For COVID-19 Jab Against Omicron
MT
06/25Pfizer says tweaked COVID-19 shots boost omicron protection
AQ
06/24INSIDER SELL : Moderna
MT
06/24Moderna COVID-19 shots now an option for older kids in US
AQ
06/24U.S. CDC backs Moderna's COVID vaccine for teens, older children
RE
06/24The next COVID booster shots will likely be updated for Omicron
RE
06/24Sanofi, GSK variant-specific COVID shot found effective against Omicron
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 22 079 M - -
Net income 2022 11 509 M - -
Net cash 2022 18 531 M - -
P/E ratio 2022 5,33x
Yield 2022 -
Capitalization 57 818 M 57 818 M -
EV / Sales 2022 1,78x
EV / Sales 2023 3,58x
Nbr of Employees 2 700
Free-Float 90,6%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 145,36 $
Average target price 213,67 $
Spread / Average Target 47,0%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-43.20%57 385
IQVIA HOLDINGS INC.-24.22%40 468
LONZA GROUP AG-32.64%39 851
SEAGEN INC.16.00%33 010
CELLTRION, INC.-11.36%18 371
ICON PUBLIC LIMITED COMPANY-28.76%17 936